MedTrace Logo

A Study to Evaluate the Efficacy Between Helicobacter Pylori Eradication Therapy and Motilitone in Functional Dyspepsia

NCT02162316 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 136

Last updated 2014-06-24

No results posted yet for this study

Summary

This is a clinical study to evaluate the efficacy between Helicobacter pylori Eradication therapy and Motilitone in Functional Dyspepsia

Conditions

  • Functional Dyspepsia

Interventions

DRUG

Motilitone®

DRUG

A-Cilin®, Clari® and Pantoline®

Sponsors & Collaborators

  • Chung-Ang University Hosptial, Chung-Ang University College of Medicine

    lead OTHER

Principal Investigators

  • Su Jin Hong, M.D., Ph.D. · Soonchunhyang University Hospital

  • Gwang Ha Kim, M.D., Ph.D. · Busan National University Hospital

  • Sang Gyun Kim, M.D., Ph.D · Seoul National University Hospital

  • Hyun Soo Kim, M.D., Ph.D · Chonnam National University Hospital

  • Seong-Woo Jeon, M.D., Ph.D · Kyungpook National University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2015-06-30
Completion
2015-10-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02162316 on ClinicalTrials.gov